-- Earnings per American depositary share ("ADS") for the fourth quarter
2007 were RMB0.82 (US$0.11), compared to RMB0.50 for the fourth quarter
Fiscal Year 2007 Financial Highlights:
Compared to fiscal year 2006 results,
-- Total net revenues increased 41.0% to RMB180.2 million (US$24.7
-- Net revenue from EPIAO increased 22.6% to RMB121.2 million (US$16.6
-- Net revenue from TPIAO increased 168.3% to RMB43.1 million (US$5.9
-- Revenue from export sales increased 15.4% to RMB6.8 million (US$0.9
-- Operating income increased 32.9% to RMB48.5 million (US$6.7 million).
-- Net income increased 167.4% to RMB81.5 million (US$11.2 million).
-- Earnings per ADS were RMB3.89 (US$0.53) in 2007, compared to RMB2.13
per ADS in 2006.
Commenting on the results, Dr. Jing Lou, Chief Executive Officer of 3SBio, said, ''2007 was a transformative year for 3SBio, driven by the successful and consistent execution of our strategy. We experienced solid growth across our core product portfolio, and delivered on a number of operational initiatives including continued progress on our development pipeline, the introduction of an oncology-focused sales team, the launch of a new product, and the successful groundbreaking on our new manufacturing facility, among others. From a product perspective, we believe our EPIAO products continued to be the market leader in terms of both revenues and sales volume. Our TPIAO products continued their strong growth, accounting for 23.9% of our total net revenues for the year, up from 12.6% for the fiscal year 2006, demonstrating the robust and rapid market acceptance of this product.''
''Our positive results for the fourth quarter and the full year 2007
are consistent with the financial and operational track record that we have
achieved since our incepti
|SOURCE 3SBio Inc.|
Copyright©2008 PR Newswire.
All rights reserved